Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Onco-Innovations Ltd. ( (TSE:ONCO) ) is now available.
Onco-Innovations Limited announced a non-brokered private placement to raise up to $2 million through the issuance of units comprising common shares and warrants. The funds will support the company’s operational and R&D objectives. Additionally, the company appointed Mr. Christopher Gulka to its Board of Directors, bringing extensive experience in capital and public markets, which could enhance Onco-Innovations’ strategic positioning in the industry.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company specializing in oncology, focusing on cancer research and treatment. The company is dedicated to pioneering research and innovative solutions for the prevention and treatment of cancer, and it holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 41,446
Technical Sentiment Signal: Strong Sell
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.